References
- Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group ‘Hypertension Arrhythmias and Thrombosis’ of the European Society of Hypertension. J Hypertens. 2012;30(2):239–252.
- Horio T, Iwashima Y, Kamide K, et al. Chronic kidney disease as an independent risk factor for new-onset atrial fibrillation in hypertensive patients. J Hypertens. 2010;28(8):1738–1744.
- Chan KE, Lazarus JM, Thadhani R, Hakim RM. Warfarin risk associates with increased risk of stroke in haemodialysis patients with atrial fibrillation. J Am Soc Nephrol. 2009;20(10):2223–2233.
- Ketteler M, Rothe H, Krüger T, et al. Mechanisms and treatment of extraosseous calcification in chronic kidney disease. Nat Rev Nephrol. 2011;7(9):509–516.
- Connely SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361(12):1139–1151.
- Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in non-valvular atrial fibrillation. N Engl J Med. 2011;365(10):883–891.
- Granger CB, Alexander JH, McMurray JJV, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365(11):981–992.
- Harper P, Young L, Merriman E. Bleeding risk with dabigatran in the frail elderly (letter). N Engl J Med. 2012;366(9):864–866.
- US bleeding ADRs higher with dabigatran than warfarin. TheHeart.org [homepage on the Internet]. c2012. Available from: http://www.theheart.org/article/1339775/print.do
- Harder S. Renal profiles of anticoagulants. J Clin Pharmacol. 2011. [Epub ahead of print].
- Fox KA, Piccini JP Wojdyla D, et al. Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment. Eur Heart J. 2011;32(19):2387–2394.
- Pisters R, Lane DA, Nieuwlaat R, et al. A novel user-friendly score (HAS-BLED) to assess one-year risk of major bleeding in patients with atrial fibrillation: The Euro Heart Survey. Chest. 2010;138(5):1093–1100.
- Lip GYH, Frison L, Halperin JL, Lane DA. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/liver function, Stroke, Bleeding history or Predisposition, Labile INR, Elderly, Drugs and Alcohol Concomitantly) score. J Am Coll Cardiol. 2011;57(2):173–180.